These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37795790)

  • 1. A nomogram prediction model for treatment failure in primary membranous nephropathy.
    Geng C; Huang L; Li Q; Li G; Li Y; Zhang P; Feng Y
    Ren Fail; 2023; 45(2):2265159. PubMed ID: 37795790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram to predict the progression of patients with primary membranous nephropathy and nephrotic syndrome.
    Liu L; Wang H; Zhao B; Liu X; Sun Y; Mao Y
    Int Urol Nephrol; 2022 Feb; 54(2):331-341. PubMed ID: 33909236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction model for treatment response of primary membranous nephropathy with nephrotic syndrome.
    Li M; Lai X; Liu J; Yu Y; Li X; Liu X
    Clin Exp Nephrol; 2024 Aug; 28(8):740-750. PubMed ID: 38709377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary nomogram model for predicting relapse of patients with primary membranous nephropathy.
    Li M; Wang H; Lai X; Guo D; Jiang C; Fu Z; Liu X
    Ren Fail; 2023 Dec; 45(1):2199092. PubMed ID: 37038751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Dynamic Prediction Model for Renal Progression in Primary Membranous Nephropathy.
    Liang Y; Li Q; Zou Z; Huang B; Zhong N; Li C; Wang A; Chen Y; Tu S; Wan J
    Int J Med Sci; 2024; 21(7):1292-1301. PubMed ID: 38818472
    [No Abstract]   [Full Text] [Related]  

  • 6. [C1q or IgA deposition in glomeruli of children with primary membranous nephropathy].
    Xu K; Wang F; Wang ZH; Sun LY; Yao Y; Xiao HJ; Liu XY; Su BG; Zhong XH; Guan N; Zhang HW; Ding J
    Zhonghua Er Ke Za Zhi; 2022 Sep; 60(9):901-907. PubMed ID: 36038299
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical significance of M
    Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study.
    Yin P; Wang J; Liang W; Zhan L; Liu Y; Lin J; Chen X; He Y; Jian H; Xie Z; Tan X; Ye Q; Huang F
    Ren Fail; 2020 Nov; 42(1):675-683. PubMed ID: 32674643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of serum anti-phospholipase A2 receptor antibody as a biomarker in membranous nephropathy: An experience from a tertiary care center of Eastern India.
    Mukherjee S; Kumar A; Maity P; Sengupta M; Basu K; Chaudhury AR; Bandopadhyay M; Chakraborty BC
    Indian J Pathol Microbiol; 2023; 66(2):269-277. PubMed ID: 37077067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction model of renal function recovery for primary membranous nephropathy with acute kidney injury.
    Chen T; Zhou Y; Zhu J; Chen X; Pan J
    BMC Nephrol; 2022 Jul; 23(1):247. PubMed ID: 35831820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of rituximab for primary membranous nephropathy with different clinical presentations: a retrospective study.
    Zhang S; Huang J; Dong J; Li Z; Sun M; Sun Y; Chen B
    Front Immunol; 2023; 14():1156470. PubMed ID: 37187749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy.
    Stefan G; Stancu S; Zugravu A; Popa O; Zubidat D; Petre N; Mircescu G
    Ren Fail; 2022 Dec; 44(1):258-268. PubMed ID: 35172682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy?
    Ragy O; Rautemaa V; Smith A; Brenchley P; Kanigicherla D; Hamilton P
    PLoS One; 2023; 18(2):e0281726. PubMed ID: 36827283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of pathological features of primary membranous nephropathy.
    Zhang XD; Cui Z; Zhang MF; Wang J; Zhang YM; Qu Z; Wang X; Huang J; Wang F; Meng LQ; Cheng XY; Wang SX; Liu G; Zhao MH
    BMC Nephrol; 2018 Aug; 19(1):215. PubMed ID: 30153817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach.
    Wang S; Deng Z; Wang Y; Bao W; Zhou S; Cui Z; Zheng D
    BMC Nephrol; 2023 May; 24(1):146. PubMed ID: 37237260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-PLA2R Antibodies in Chinese Patients with Membranous Nephropathy.
    Li X; Wei D; Zhou Z; Wang B; Xu Y; Pan J; Yang C; Lu J; Qiu Y
    Med Sci Monit; 2016 May; 22():1630-6. PubMed ID: 27179439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy.
    Liang J; Hao W; Xia F; Zhao Z; Wu Y; Yu F; Hu W; Fang X; Liu W
    Ren Fail; 2023 Dec; 45(1):2212081. PubMed ID: 37194712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLA2R antibody, PLA2R rs4664308 polymorphism and PLA2R mRNA levels in Tunisian patients with primary membranous nephritis.
    Dhaouadi T; Abdellatif J; Trabelsi R; Gaied H; Chamkhi S; Sfar I; Goucha R; Ben Hamida F; Ben Abdallah T; Gorgi Y
    PLoS One; 2020; 15(10):e0240025. PubMed ID: 33002091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians.
    Ramachandran R; Kumar V; Kumar A; Yadav AK; Nada R; Kumar H; Kumar V; Rathi M; Kohli HS; Gupta KL; Sakhuja V; Jha V
    Nephrol Dial Transplant; 2016 Sep; 31(9):1486-93. PubMed ID: 26673907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological Characteristics and Outcomes of PLA
    Luo J; Yuan Y; Tian J; Zhou Z; Su C; Yang F; Wang G
    Am J Kidney Dis; 2022 Sep; 80(3):364-372. PubMed ID: 35288217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.